Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.94 |
| ▸ | SQLE | Q14534 | 8/20 | 0.77 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | FNTA | P49354 | 1/20 | 0.63 |
| ▸ | FNTB | P49356 | 1/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Squalene SCHEMBL2515732 | 1.00 | KMT2A (0.94) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL39067 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL890053 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL4444267 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL8013144 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL23802597 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL8819997 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL21823197 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL21639794 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL2799805 | 0.97 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12343419-B2 | Topical composition | FRAMERGY INC. (US) | 2025-07-01 | — | — | US | claimed |
| CN-115813794-A | Method for improving hair quality by improving scalp health | 宝洁公司 | 2023-03-21 | — | — | CN | claimed |
| US-20220142889-A1 | TOPICAL COMPOSITION | FRAMERGY INC. | 2022-05-12 | — | — | US | claimed |
| EP-3946226-A1 | MOF COMPRISING TOPICAL COMPOSITION | Framergy Inc. (US) | 2022-02-09 | — | — | EP | claimed |
| WO-2020204876-A1 | MOF COMPRISING TOPICAL COMPOSITION | FRAMERGY INC. (US) | 2020-10-08 | — | — | WO | claimed |
| EP-2972324-B1 | A NONINVASIVE METHOD FOR DIAGNOSING A DANDRUFF CONDITION | PROCTER & GAMBLE (US) | 2020-04-22 | — | — | EP | claimed |
| US-10410846-B2 | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics | WATERS TECHNOLOGIES CORPORATION (US) | 2019-09-10 | — | — | US | claimed |
| US-20180190479-A1 | MOLECULAR DIAGNOSTICS IN PERSONALIZED DERMATOLOGY, DERMATOPATHOLOGY AND COSMETICS | WATERS TECHNOLOGIES CORPORATION | 2018-07-05 | — | — | US | claimed |
| EP-3302407-A1 | A METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | The Procter and Gamble Company (US) | 2018-04-11 | — | — | EP | claimed |
| EP-3287783-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | The Procter & Gamble Company (US) | 2018-02-28 | — | — | EP | claimed |
| US-9881777-B2 | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics | WATERS TECHNOLOGIES CORPORATION (US) | 2018-01-30 | — | — | US | claimed |
| US-20170004957-A1 | MOLECULAR DIAGNOSTICS IN PERSONALIZED DERMATOLOGY, DERMATOPATHOLOGY AND COSMETICS | WATERS TECHNOLOGIES CORPORATION (US) | 2017-01-05 | — | — | US | claimed |
| US-20160346184-A1 | METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | THE PROCTER & GAMBLE COMPANY | 2016-12-01 | — | — | US | claimed |
| WO-2016191518-A1 | A METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-01 | — | — | WO | claimed |
| EP-2972324-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | The Procter & Gamble Company (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014144265-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-18 | — | — | WO | claimed |
| US-20140273055-A1 | NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN: OXIDATIVE STRESS AND OXIDATIVE DAMAGE BIOMARKERS | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-18 | — | — | US | claimed |
| US-20140234420-A1 | Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions | SOUTH DAKOTA STATE UNIVERSITY | 2014-08-21 | — | — | US | claimed |
| WO-2014028608-A1 | METHOD OF TREATING SKIN DISORDERS USING NANOSCALE DELIVERY DEVICES AND TRANSDERMAL ENHANCING COMPOSITIONS | SOUTH DAKOTA STATE UNIVERSITY (US) | 2014-02-20 | — | — | WO | claimed |
| CN-122005383-A | Oily skin care composition and preparation method and application thereof | 北京东方淼森生物科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4627102-A1 | INGREDIENT MIXTURES EFFECTIVE TO MODIFY RATIOS OF BENEFICIAL MICROBIAL SPECIES TO NON-BENEFICIAL MICROBIAL SPECIES MIXTURES | Arcaea, LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-12343419-B2 | Topical composition | FRAMERGY INC. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-3950012-B1 | METHOD FOR INACTIVATING BACTERIA OR VIRUSES AND INACTIVATING APPARATUS FOR BACTERIA OR VIRUSES | USHIO ELECTRIC INC (JP) | 2025-04-09 | — | — | EP | disclosed |
| WO-2025051456-A1 | PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2025-03-13 | — | — | WO | disclosed |
| US-20250032569-A1 | COMPOSITION, IN PARTICULAR COSMETIC FORMULATION, COMPRISING A VERBASCOSIDE EXTRACT | MEDENA AG (CH) | 2025-01-30 | — | — | US | disclosed |
| WO-2024254969-A1 | ACNE CLEARING COMPOSITION FOR OPTIMIZING SKIN GREASE MASS, PREPARATION METHOD THEREFOR AND USE THEREOF | 诺德溯源(广州)生物科技有限公司 | 2024-12-19 | — | — | WO | disclosed |
| US-20240345054-A1 | Method of Screening Antioxidants | KENVUE BRANDS LLC | 2024-10-17 | — | — | US | disclosed |
| EP-3880304-B1 | COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING | S BIOMEDIC NV (BE) | 2024-10-16 | — | — | EP | disclosed |
| EP-4436541-A1 | COMPOSITION, IN PARTICULAR COSMETIC FORMULATION, COMPRISING A VERBASCOSIDE EXTRACT | Medena AG (CH) | 2024-10-02 | — | — | EP | disclosed |
| US-20240315952-A1 | PERSONAL CARE COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-09-26 | — | — | US | disclosed |
| CN-118488825-A | Composition, in particular cosmetic preparation, comprising a acteoside extract | 麦迪那股份公司 | 2024-08-13 | — | — | CN | disclosed |
| WO-2024118975-A1 | INGREDIENT MIXTURES EFFECTIVE TO MODIFY RATIOS OF BENEFICIAL MICROBIAL SPECIES TO NON-BENEFICIAL MICROBIAL SPECIES MIXTURES | Arcaea, LLC (US) | 2024-06-06 | — | — | WO | disclosed |
| CN-114760982-B | Composition comprising a cationic polysaccharide and an anionic antioxidant | 莱雅公司 | 2024-05-31 | — | — | CN | disclosed |
| EP-4370906-A1 | METHOD OF SCREENING ANTIOXIDANTS | JOHNSON & JOHNSON CONSUMER INC. (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-117693675-A | Method for screening antioxidants | 强生消费者公司 | 2024-03-12 | — | — | CN | disclosed |
| US-20240042424-A1 | CITY POLLUTION ENVIRONMENT SIMULATION APPARATUS | BASF SE (DE) | 2024-02-08 | — | — | US | disclosed |
| EP-4267102-A1 | PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-11-01 | — | — | EP | disclosed |
| CN-116600775-A | Extracts of at least one plant of the crocus species containing a high content of crocin and a low content of crocin aldehyde, and cosmetic use thereof as antioxidant | 莱雅公司 | 2023-08-15 | — | — | CN | disclosed |
| WO-2023093998-A1 | COMPOSITION, IN PARTICULAR COSMETIC FORMULATION, COMPRISING A VERBASCOSIDE EXTRACT | MEDENA AG (CH) | 2023-06-01 | — | — | WO | disclosed |
| US-11642425-B2 | Method for inactivating bacteria or viruses and inactivating apparatus for bacteria or viruses | USHIO DENKI KABUSHIKI KAISHA (JP) | 2023-05-09 | — | — | US | disclosed |
| CN-115813794-A | Method for improving hair quality by improving scalp health | 宝洁公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-2023286015-A1 | METHOD OF SCREENING ANTIOXIDANTS | JOHNSON & JOHNSON CONSUMER INC. (US) | 2023-01-19 | — | — | WO | disclosed |
| CN-114793434-A | 3-phenylsulfonyl-quinoline derivatives as agents for the treatment of pathogenic vascular disorders | 加利福尼亚大学董事会 | 2022-07-26 | — | — | CN | disclosed |
| CN-114760982-A | Compositions comprising cationic polysaccharides and anionic antioxidants | 莱雅公司 | 2022-07-15 | — | — | CN | disclosed |
| WO-2022135883-A1 | PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-06-30 | — | — | WO | disclosed |
| US-20220142889-A1 | TOPICAL COMPOSITION | FRAMERGY INC. | 2022-05-12 | — | — | US | disclosed |
| US-20220040344-A1 | METHOD FOR INACTIVATING BACTERIA OR VIRUSES AND INACTIVATING APPARATUS FOR BACTERIA OR VIRUSES | USHIO DENKI KABUSHIKI KAISHA (JP) | 2022-02-10 | — | — | US | disclosed |
| EP-3946226-A1 | MOF COMPRISING TOPICAL COMPOSITION | Framergy Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| EP-3950012-A1 | METHOD FOR INACTIVATING BACTERIA OR VIRUSES AND INACTIVATING APPARATUS FOR BACTERIA OR VIRUSES | Ushio Denki Kabushiki Kaisha (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-20220000762-A1 | COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING AND DIAGNOSIS OF OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES | S-biomedic N.v. (BE) | 2022-01-06 | — | — | US | disclosed |
| CN-113546187-A | Method and apparatus for inactivating fungi or viruses | 优志旺电机株式会社 | 2021-10-26 | — | — | CN | disclosed |
| EP-3880304-A1 | COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING AND DIAGNOSIS OF OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES | S-Biomedic NV (BE) | 2021-09-22 | — | — | EP | disclosed |
| CN-113038959-A | Composition for treating oxidative stress-related skin diseases and skin aging and diagnosis of oxidative stress-related skin diseases | S-生物医药有限公司 | 2021-06-25 | — | — | CN | disclosed |
| US-20210138448-A1 | A CITY POLLUTION ENVIRONMENT SIMULATION APPARATUS | BASF SE (DE) | 2021-05-13 | — | — | US | disclosed |
| CN-112292111-A | Method for providing customized shade sun products | 欧莱雅 | 2021-01-29 | — | — | CN | disclosed |
| CN-112236123-A | Customized shade sun protection product | 欧莱雅 | 2021-01-15 | — | — | CN | disclosed |
| WO-2020204876-A1 | MOF COMPRISING TOPICAL COMPOSITION | FRAMERGY INC. (US) | 2020-10-08 | — | — | WO | disclosed |
| EP-3364964-B1 | COMPOSITION BASED ON DIHYDROMYRICETIN AND A ZINC SALT FOR THE TREATMENT OF ACNE AND OILY SKIN | THOREL JEAN NOEL (FR) | 2020-08-26 | — | — | EP | disclosed |
| WO-2020099663-A1 | COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING AND DIAGNOSIS OF OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES | S-biomedic N.v. (BE) | 2020-05-22 | — | — | WO | disclosed |
| EP-2972324-B1 | A NONINVASIVE METHOD FOR DIAGNOSING A DANDRUFF CONDITION | PROCTER & GAMBLE (US) | 2020-04-22 | — | — | EP | disclosed |
| WO-2020052994-A1 | METHOD OF EVALUATING EFFICACY OF COSMETIC COMPOSITIONS | UNILEVER N.V. (NL) | 2020-03-19 | — | — | WO | disclosed |
| EP-3287783-B1 | A NONINVASIVE METHOD FOR DIAGNOSING A DANDRUFF CONDITION BY MEASURING OXIDIZED LIPIDS IN SKIN SAMPLES | PROCTER & GAMBLE (US) | 2020-02-26 | — | — | EP | disclosed |
| CN-106243006-B | (3-alkylthio) acrylic acid derivative compound and cosmetic application thereof | 爱西美有限公司 | 2019-12-31 | — | — | CN | disclosed |
| US-10410846-B2 | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics | WATERS TECHNOLOGIES CORPORATION (US) | 2019-09-10 | — | — | US | disclosed |
| US-10098849-B2 | Anti-radical agents | BASF SE (DE) | 2018-10-16 | — | — | US | disclosed |
| EP-3364964-A1 | COMPOSITION BASED ON DIHYDROMYRICETIN AND A ZINC SALT FOR THE TREATMENT OF ACNE AND OILY SKIN | Thorel, Jean-Noël (FR) | 2018-08-29 | — | — | EP | disclosed |
| US-20180190479-A1 | MOLECULAR DIAGNOSTICS IN PERSONALIZED DERMATOLOGY, DERMATOPATHOLOGY AND COSMETICS | WATERS TECHNOLOGIES CORPORATION | 2018-07-05 | — | — | US | disclosed |
| EP-3302407-A1 | A METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | The Procter and Gamble Company (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-3287783-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | The Procter & Gamble Company (US) | 2018-02-28 | — | — | EP | disclosed |
| US-9881777-B2 | Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics | WATERS TECHNOLOGIES CORPORATION (US) | 2018-01-30 | — | — | US | disclosed |
| CN-104364361-B | Improvements relating to fabric freshness | 荷兰联合利华有限公司 | 2017-07-21 | — | — | CN | disclosed |
| WO-2017068424-A1 | COMPOSITION BASED ON DIHYDROMYRICETIN AND A ZINC SALT FOR THE TREATMENT OF ACNE AND OILY SKIN | THOREL JEAN-NOëL (FR) | 2017-04-27 | — | — | WO | disclosed |
| US-20170004957-A1 | MOLECULAR DIAGNOSTICS IN PERSONALIZED DERMATOLOGY, DERMATOPATHOLOGY AND COSMETICS | WATERS TECHNOLOGIES CORPORATION (US) | 2017-01-05 | — | — | US | disclosed |
| EP-1695663-B1 | Method for evaluating the skin potential of deactivating free radicals | L'ORÉAL (FR) | 2016-12-07 | — | — | EP | disclosed |
| US-20160346184-A1 | METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | THE PROCTER & GAMBLE COMPANY | 2016-12-01 | — | — | US | disclosed |
| WO-2016191518-A1 | A METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-01 | — | — | WO | disclosed |
| EP-1698325-B1 | Compositions containing amines and use thereof | JOHNSON & JOHNSON CONSUMER (US) | 2016-07-20 | — | — | EP | disclosed |
| EP-2972324-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | The Procter & Gamble Company (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2841543-B1 | IMPROVEMENTS RELATING TO FABRIC FRESHNESS | UNILEVER PLC (GB) | 2016-01-20 | — | — | EP | disclosed |
| EP-2877577-A1 | EXTRACTS ISOLATED FROM ELECTROPORATED AMBHIBIAN OOCYTES AND USE THEREOF IN TREATING DISEASES AND DISORDERS | Bioquark, Inc. (US) | 2015-06-03 | — | — | EP | disclosed |
| CN-104364361-A | Improvements relating to fabric freshness | UNILEVER NV | 2015-02-18 | — | — | CN | disclosed |
| EP-2583662-B1 | Composition comprising a meroterpen to manage oily skin with tendency to develop acne | THOREL JEAN-NOëL (FR) | 2014-10-01 | — | — | EP | disclosed |
| US-20140273055-A1 | NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN: OXIDATIVE STRESS AND OXIDATIVE DAMAGE BIOMARKERS | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2014144265-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140234420-A1 | Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions | SOUTH DAKOTA STATE UNIVERSITY | 2014-08-21 | — | — | US | disclosed |
| WO-2014028608-A1 | METHOD OF TREATING SKIN DISORDERS USING NANOSCALE DELIVERY DEVICES AND TRANSDERMAL ENHANCING COMPOSITIONS | SOUTH DAKOTA STATE UNIVERSITY (US) | 2014-02-20 | — | — | WO | disclosed |
| US-20140030244-A1 | EXTRACTS ISOLATED FROM ELECTROPORATED AMBHIBIAN OOCYTES AND USE THEREOF IN TREATING DISEASES AND DISORDERS | BIOQUARK, INC. (US) | 2014-01-30 | — | — | US | disclosed |
| WO-2014018663-A1 | EXTRACTS ISOLATED FROM ELECTROPORATED AMBHIBIAN OOCYTES AND USE THEREOF IN TREATING DISEASES AND DISORDERS | BIOQUARK, INC. (US) | 2014-01-30 | — | — | WO | disclosed |
| EP-2583662-A1 | Composition comprising a meroterpen to manage oily skin with tendency to develop acne | Thorel, Jean-Noël (FR) | 2013-04-24 | — | — | EP | disclosed |
| US-20120328541-A1 | Anti-radical agents | BASCHONG WERNER (CH) | 2012-12-27 | — | — | US | disclosed |
| US-8278359-B2 | Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2012-10-02 | — | — | US | disclosed |
| US-8084268-B2 | Method of evaluating the potential of the skin for scavenging free radicals | L'OREAL (FR) | 2011-12-27 | — | — | US | disclosed |
| US-8034788-B2 | Composition and methods for skin care | DERMIPSOR LTD. (IL) | 2011-10-11 | — | — | US | disclosed |
| WO-2010120875-A2 | TREATMENT OF SKIN DAMAGE | EUKARION INC. | 2010-10-21 | — | — | WO | disclosed |
| US-20100267825-A1 | TREATMENT OF SKIN DAMAGE | EUKARION, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| EP-1827406-B1 | ANTI-RADICAL AGENTS | BASF SE (DE) | 2010-07-28 | — | — | EP | disclosed |
| US-20080312181-A1 | Composition and Methods for Skin Care | DERMIPSOR LTD. (IL) | 2008-12-18 | — | — | US | disclosed |
| US-20080305055-A1 | Anti-Radical Agents | CIBA CORPORATION | 2008-12-11 | — | — | US | disclosed |
| US-20080193397-A1 | Use of Peroxide Decomposers Method For the Treatment of a Material Other Than the Human Body | BASF AKTIENGESELLSCAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| EP-1879449-A2 | COMPOSITIONS AND METHODS FOR SKIN CARE | DERMIPSOR LTD (IL) | 2008-01-23 | — | — | EP | disclosed |
| EP-1827406-A1 | ANTI-RADICAL AGENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2007-09-05 | — | — | EP | disclosed |
| US-20070042010-A1 | Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin | JOHNSON & JOHNSON CONSUMER INC. | 2007-02-22 | — | — | US | disclosed |
| WO-2006120681-A2 | COMPOSITIONS AND METHODS FOR SKIN CARE | DERMIPSOR LTD. (IL) | 2006-11-16 | — | — | WO | disclosed |
| US-20060257335-A1 | Compositions containing amines and use thereof to darken the skin | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2006-11-16 | — | — | US | disclosed |
| EP-1698325-A1 | Compositions containing amines and use thereof | Johnson & Johnson Consumer Companies, Inc. (US) | 2006-09-06 | — | — | EP | disclosed |
| US-20060194333-A1 | Method of evaluating the potential of the skin for scavenging free radicals | L'OREAL (FR) | 2006-08-31 | — | — | US | disclosed |
| EP-1695663-A2 | Method for evaluating the skin potential of deactivating free radicals | L'OREAL (FR) | 2006-08-30 | — | — | EP | disclosed |
| WO-2006066987-A1 | ANTI-RADICAL AGENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-06-29 | — | — | WO | disclosed |
| EP-0955035-B1 | Method of preventing aged body odor | SHISEIDO CO LTD (JP) | 2004-09-29 | — | — | EP | disclosed |
| EP-0967969-B1 | NOVEL ANTIOXIDANT MIXTURE | COLOR ACCESS INC (US) | 2004-09-22 | — | — | EP | disclosed |
| US-20030229149-A1 | Anti-inflammatory agents | BASCHONG WERNER (CH) | 2003-12-11 | — | — | US | disclosed |
| EP-1366763-A1 | Hydroxy diphenyl ether compounds as anti-inflammatory agents | Ciba SC Holding AG (CH) | 2003-12-03 | — | — | EP | disclosed |
| CN-1437580-A | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | HAARMANN & REIMER GMBH (DE) | 2003-08-20 | — | — | CN | disclosed |
| US-20030139470-A1 | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | HAARMANN & REIMER GMBH (DE) | 2003-07-24 | — | — | US | disclosed |
| US-20030053967-A1 | Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light | HAARMANN & REIMER GMBH (DE) | 2003-03-20 | — | — | US | disclosed |
| US-20030049287-A1 | Catechol oximes and their use in cosmetic and dermatological preparations | HAARMANN & REIMER GMBH (DE) | 2003-03-13 | — | — | US | disclosed |
| US-6342486-B1 | SKIN DISORDER TREATMENT WITH GLYCANS FOR ANTIINFLAMMATORY AGENTS | MIBELLE AG COSMETICS (CH) | 2002-01-29 | — | — | US | disclosed |
| US-6068848-A | Antioxidant mixture comprising tocopherol | COLOR ACCESS, INC. (US) | 2000-05-30 | — | — | US | disclosed |
| JP-2000086621-A | PRODUCTION OF SQUALENE PEROXIDE | YAKULT HONSHA CO LTD | 2000-03-28 | — | — | JP | disclosed |
| EP-0967969-A1 | NOVEL ANTIOXIDANT MIXTURE | Color Access, Inc. (US) | 2000-01-05 | — | — | EP | disclosed |
| EP-0955035-A1 | Body odor preventing composition | SHISEIDO COMPANY LIMITED (JP) | 1999-11-10 | — | — | EP | disclosed |
| WO-1999030682-A1 | NOVEL ANTIOXIDANT MIXTURE | COLOR ACCESS, INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| EP-0601698-B1 | Topical composition comprising tocopherol | SHISEIDO CO LTD (JP) | 1998-07-08 | — | — | EP | disclosed |
| US-5415875-A | Applying hydrolyzed shell membrane and tocopherol derivative; aging and oxidation resistance | SHISEIDO CO., LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| EP-0601698-A1 | Topical composition comprising tocopherol | SHISEIDO COMPANY LIMITED (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0601698-A1 | Topical composition comprising tocopherol | SHISEIDO COMPANY LIMITED (JP) | 1994-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234420-A1 | Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions | RARA, MTX1, RARB | KMT2A 3774/4885SQLE 475/4885MAPT 1281/4885 |
| US-20080193397-A1 | Use of Peroxide Decomposers Method For the Treatment of a Material Other Than the Human Body | GPX4, LPO, GPX1 | KMT2A 2854/4885SQLE 282/4885MAPT 2926/4885 |
| US-20120328541-A1 | Anti-radical agents | NOS3, GSTO1, TXN2 | KMT2A 3587/4885SQLE 960/4885MAPT 4702/4885 |
| US-20060257335-A1 | Compositions containing amines and use thereof to darken the skin | H1-0, TYR, H1-3 | KMT2A 198/4885SQLE 771/4885MAPT 3771/4885 |
| US-20220142889-A1 | TOPICAL COMPOSITION | CUTA, TYR, ERCC4 | KMT2A 3630/4885SQLE 3072/4885MAPT 239/4885 |
| US-20070042010-A1 | Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin | CUTA, C3AR1, HCAR3 | KMT2A 2577/4885SQLE 84/4885MAPT 4323/4885 |
| US-20100267825-A1 | TREATMENT OF SKIN DAMAGE | CAT, GPX4, GPX1 | KMT2A 4038/4885SQLE 419/4885MAPT 2454/4885 |
| US-20080305055-A1 | Anti-Radical Agents | NOS3, GSTO1, PTGS1 | KMT2A 3828/4885SQLE 1116/4885MAPT 4783/4885 |
| US-10098849-B2 | Anti-radical agents | NOS3, GSTO1, TXN2 | KMT2A 3587/4885SQLE 960/4885MAPT 4702/4885 |
| US-12343419-B2 | Topical composition | CUTA, TYR, ERCC4 | KMT2A 3630/4885SQLE 3072/4885MAPT 239/4885 |
| US-20030049287-A1 | Catechol oximes and their use in cosmetic and dermatological preparations | TYR, LPO, COMT | KMT2A 955/4885SQLE 54/4885MAPT 2433/4885 |
| US-20030139470-A1 | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | TYR, HAAO, TH | KMT2A 1334/4885SQLE 799/4885MAPT 1335/4885 |
| US-20220000762-A1 | COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING AND DIAGNOSIS OF OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES | CUTA, LPO, PPOX | KMT2A 4635/4885SQLE 163/4885MAPT 4209/4885 |
| US-20030229149-A1 | Anti-inflammatory agents | CCR1, CCR10, CCRL2 | KMT2A 4602/4885SQLE 2104/4885MAPT 4684/4885 |
| US-20160346184-A1 | METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | GPX4, GPX1, COXFA4L2 | KMT2A 2018/4885SQLE 2009/4885MAPT 2729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.